2003
DOI: 10.1046/j.1365-3024.2003.00619.x
|View full text |Cite
|
Sign up to set email alerts
|

Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14

Abstract: Fasciola hepatica is the causative agent of fasciolosis in many areas in America, Europe, Africa, Asia and Australia. There is an urgent need for improved methods to control the parasite's transmission. We describe the use of an experimental vaccine based on a recombinant antigen cloned from another parasite, Schistosoma mansoni (Sm14), that induces high levels of cross protection in mice against both S. mansoni and F. hepatica. Sheep and mice vaccinated with Sm14 were significantly protected against challenge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
25
1
1

Year Published

2005
2005
2019
2019

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(28 citation statements)
references
References 12 publications
1
25
1
1
Order By: Relevance
“…The presence of high levels of antibodies to F. hepatica ES antigens in the animals that acquired immunity against infection suggests that antibodies could have contributed to the protection. This is consistent with observations made by other authors who, using immunogens other than FhSAP2, found associations between protection and the levels of antibodies (Acosta et al, 2008; Almeida et al, 2003; Law et al, 2003; Martinez-Fernandez et al, 2004; Meeusen and Piedrafita, 2003; Ramajo et al, 2001; Reszka et al, 2005; Sexton et al, 1994; Smooker et al, 2004; Vilar et al, 2003; Zafra et al, 2008). Because FhSAP2 is a lytic protein, FhSAP2 could be involved in acquiring nutrition for the liver fluke and/or its migration through the liver parenchyma (Espino and Hillyer, 2003).…”
Section: Discussionsupporting
confidence: 93%
“…The presence of high levels of antibodies to F. hepatica ES antigens in the animals that acquired immunity against infection suggests that antibodies could have contributed to the protection. This is consistent with observations made by other authors who, using immunogens other than FhSAP2, found associations between protection and the levels of antibodies (Acosta et al, 2008; Almeida et al, 2003; Law et al, 2003; Martinez-Fernandez et al, 2004; Meeusen and Piedrafita, 2003; Ramajo et al, 2001; Reszka et al, 2005; Sexton et al, 1994; Smooker et al, 2004; Vilar et al, 2003; Zafra et al, 2008). Because FhSAP2 is a lytic protein, FhSAP2 could be involved in acquiring nutrition for the liver fluke and/or its migration through the liver parenchyma (Espino and Hillyer, 2003).…”
Section: Discussionsupporting
confidence: 93%
“…These include Sm23 [39-45], integral membrane protein 25 [46], Sm14 [47,48], and 26 and 28 glutathione S-transferases [49-52]. …”
Section: Resultsmentioning
confidence: 99%
“…However, these strong cellular and humoral immune responses did not protect against future challenges. Recently, high levels of protection have been obtained in sheep with purified cathepsin L proteases [8,10,17,25] and recombinant antigen Sm14 [1]. Nonetheless, their specific protective mechanisms are yet to be elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…These studies reported that sheep do not develop resistance to reinfection. However, more recent studies have demonstrated that some immunisation protocols induce a significant protective response against challenge infection in sheep [1,25] and cattle [19,20]. Therefore, there are many questions concerning the immunological basis of susceptibility and resistance in sheep that should be elucidated [1,8,9,18].…”
Section: Introductionmentioning
confidence: 99%